ReviewNature methods2026
Guidance for 3D traction force microscopy today and in the next decade.
Review in Nature methods, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The field of mechanobiology studies how mechanical forces influence cell behavior, relying on tools like traction force microscopy (TFM) to quantify cell forces exerted on the extracellular matrix. While well established for two-dimensional in vitro systems, its three-dimensional form, 3DTFM, remains underutilized despite notable technical advancements. Here, we outline common skepticism about 3DTFM, detailing current experimental and computational strategies to address its limitations. We describe how to integrate 3DTFM with biological readouts, focusing on its application in long-term experiments. We discuss metrics for data interpretation and how pairing these with optimal traction recovery methods can address specific biological questions. Finally, we outline future directions by proposing combinations with emerging technologies to address challenges like extracellular matrix heterogeneity and intracellular stress analysis within three-dimensional cell clusters. By addressing these critical gaps, this Perspective aims to advance 3DTFM's utility, promote its broader adoption and guide future developments in mechanobiology.
Indexed as
Identifiers
41461906What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.